Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico (FSW-IDU)
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Efficacy Study; Intervention Model: Factorial Assignment; Masking: Double Blind (Subject, Investigator); Primary Purpose: Prevention |
| Conditions: |
HIV HIV Infections |
| Interventions: |
Behavioral: Interactive injection and sexual risk intervention Behavioral: Interactive Sexual Risk Intervention Behavioral: Interactive Injection Risk Intervention |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
|
Study recruitment took place between October 28, 2008 through May 31, 2010 in Tijuana and November 15, 2008 through July 30, 2010 in Ciudad Juarez. Data Collection for this study has been completed and the study is in the analysis phase. |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| Targeted sampling techniques were used. Potential participants were approached at venues such as motels, hotels, brothels, shooting galleries, bars, alleys and street corners in both cities. Interested parties were referred to the project offices or a mobile unit for eligibility screening. |
Reporting Groups
| Description | |
|---|---|
| A: Didactic Safer Injection & Sexual Activity Education |
In each city, 75 women will participate in a 60 minute didactic presentation and printed materials on safer sex and safer injection based on Centers for Disease Control and Prevention (CDC) guidelines for Human Immuno-deficiency Virus (HIV) counseling, testing, and referral and materials from Mexico's National Center for AIDS (Acquired Immuno-Deficiency Syndrome)Studies (CENSIDA). In this component, there will be no theory-driven active skill building elements oriented towards safer sex or safer injection. |
| B: Interactive Injection Risk & Didactic Safer Sex Education |
In each city, 75 women will participate in the 60 minute "Di No a las Jeringas Contaminadas" ['Say No to Contaminated Syringes'] counseling session. This one on one intervention incorporates elements of motivational interviewing (MI) and principles of social cognitive theory and theory of reasoned action(SCT/TRA) to address the context of unsafe injection sharing and the extent to which syringes and other injection paraphernalia is shared. In addition, participants will be provided a lecture-type presentation on safer sex. However, in this component, there will be no theory-driven active skill building elements oriented towards safer sex. |
| C:Interactive Sexual Risk & Didactic Safer Injection Eductatio |
In each city, 75 women will participate in the 60 minute "Di No Al Sexo Inseguro" [Say No to Unsafe Sex'] counseling session. This one on one intervention incorporates elements of MI and principles of social cognitive theory and theory of reasoned action (SCT/TRA)to address the context of unsafe sex and condom use with clients. In addition, participants will be provided a lecture-type presentation on safer injection sharing. However, in this component, there will be no theory-driven active skill building elements oriented towards safer injection behavior. |
| D: Interactive Injection & Sexual Risk Intervention |
In each city, 75 women will participate in the 60 minute "Di No a las Jeringas Contaminadas" ['Say No to Contaminated Syringes'] and "Di No Al Sexo Inseguro" [Say No to Unsafe Sex'] counseling session. This one-on-one intervention incorporates elements of MI and principles of social cognitive theory and theory of reasoned action (SCT/TRA) to address the context of both, a) unsafe injection sharing and the extent to which syringes and other injection paraphernalia is shared; and b) unsafe sex and condom use with clients, and associated risks (e.g., Human Immuno-deficiency Virus (HIV)infection,Sexually Transmitted Infections (STIs, pregnancy). |
Participant Flow: Overall Study
| A: Didactic Safer Injection & Sexual Activity Education | B: Interactive Injection Risk & Didactic Safer Sex Education | C:Interactive Sexual Risk & Didactic Safer Injection Eductatio | D: Interactive Injection & Sexual Risk Intervention | |
|---|---|---|---|---|
| STARTED | 144 | 146 | 148 | 146 |
| COMPLETED | 139 [1] | 143 [1] | 143 [1] | 142 [1] |
| NOT COMPLETED | 5 | 3 | 5 | 4 |
| Death | 2 | 2 | 3 | 3 |
| Lost to Follow-up | 3 | 1 | 2 | 1 |
| [1] | We defined "completed" as having at least one follow-up visit |
|---|
Outcome Measures
| 1. Primary: | Combined HIV/STI 12-month Incidence Rates of HIV, Syphilis, Chlamydia, Gonorrhea and Trichomonas Vaginalis. [ Time Frame: 12 months, with measuring points at baseline and at 4, 8, and 12 months past baseline ] |
| 2. Secondary: | Change (Baseline to 4-, 8-, and 12-months) in the a)Mean Number of Unprotected Sex Acts With Clients and b)Ratio of Unprotected Sex Acts With Clients (Relative to the Number of Sex Acts With Clients. [ Time Frame: 12 months, with measuring points at baseline and at 4, 8, and 12 months past baseline ] |
| 3. Secondary: | Change (Baseline to 4-, 8-, and 12-months) in the a) Proportional Odds of Higher Receptive Needle Sharing and b) Mean Score of the Injection Risk Index (IRI). [ Time Frame: 12 months, with measuring points at baseline and at 4, 8, and 12 months past baseline ] |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| Observed important site differences at enrollment need to be considered in outcome analysis. |
Results Point of Contact:
Organization: University of California, San Diego
phone: (858) 822-1952
e-mail: sstrathdee@ucsd.edu
No publications provided by University of California, San Diego
Publications automatically indexed to this study:
| Responsible Party: | Steffanie Strathdee, University of California, San Diego |
| ClinicalTrials.gov Identifier: | NCT00840658 History of Changes |
| Obsolete Identifiers: | NCT01719939 |
| Other Study ID Numbers: | DESPR R01DA023877, R01DA023877, 5R01DA023877-02 |
| Study First Received: | February 7, 2009 |
| Results First Received: | July 2, 2012 |
| Last Updated: | January 16, 2013 |
| Health Authority: | United States: Federal Government Mexico: Ministry of Health |